Humira (adalimumab) - AbbVie
budesonide - Generic mfg.
Stelara (ustekinumab) - J&J
Entyvio (vedolizumab) - Takeda
Clinical characteristics and treatment outcomes in pediatric microscopic colitis: A retrospective 13-year experience. (PubMed, J Pediatr Gastroenterol Nutr) - Oct 14, 2026 - "This study adds to the limited pediatric MC literature, including two cases requiring biologic therapy. Fecal calprotectin is presently underutilized but, when tested, was not reliably elevated in the active disease state. Like adults, Budesonide was the most prescribed therapy for pediatric MC and may represent an important first line treatment option due to select patients exhibiting complete symptomatic response." 
Journal • Retrospective data • Celiac Disease • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammation • Pain • Pediatrics
http://www.ncbi.nlm.nih.gov/pubmed/42865120
 
Kamryn Jebb; Kendall Kleinman; Maureen M Leonard; Stephanie Camhi; Victoria Kenyon; Victoria M Martin
 
Oct 14, 2026
 
Prev Next